Drug development for severe asthma: What are the metrics?
- 1 August 2012
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 135 (2) , 176-181
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Severe Asthma: Lessons Learned from the National Heart, Lung, and Blood Institute Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?Journal of Allergy and Clinical Immunology, 2011
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthmaClinical & Experimental Allergy, 2009
- A retrospective randomized study of asthma control in the US: results of the CHARIOT studyCurrent Medical Research and Opinion, 2008
- Asthma cases attributable to atopy: Results from the Third National Health and Nutrition Examination SurveyJournal of Allergy and Clinical Immunology, 2007
- Airway remodeling and lack of bronchodilator response in steroid-resistant asthmaJournal of Allergy and Clinical Immunology, 2007
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research ProgramJournal of Allergy and Clinical Immunology, 2007
- Characteristics of Bronchial Asthma with Incomplete Reversibility of Airflow ObstructionAnnals of Allergy, Asthma & Immunology, 1997